tag drug-diagnostics 
XTalks
APRIL 18, 2024
Roche has received Breakthrough Device designation from the US Food and Drug Administration (FDA) for its Elecsys pTau217 early Alzheimer’s blood test. Consequently, there is a critical role for diagnostics to play in addressing this global health challenge,” said Matt Sause, CEO of Roche Diagnostics, in the company’s news release. “We
Rethinking Clinical Trials
OCTOBER 26, 2023
There is a lack of point-of-care diagnostics; it can take up to 3 steps to treatment initiation. point of care diagnostic tests, provide broad access to curative Hepatitis C medications with a national subscription model, with Medicare co-pay assistance and commercial insurance coverage. The initiative would bring to the U.S.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Roots Analysis
JANUARY 28, 2024
Velocity: Big Data needs to be handled promptly as businesses generate data at an unprecedented speed, driven by the growing adoption of Internet of Things (IoT), and technologies, such as RFID tags, sensors, and smart meters are used to deal with the high velocity of data in real-time. It is loosely arranged into categories using meta tags.
Pharmaceutical Technology
MAY 15, 2023
Innovation S-curve for the pharmaceutical industry Peptide nano-particle conjugates is a key innovation area in the pharmaceutical industry By tagging peptides with nanoparticles, peptide nano-particle conjugates allow enhanced control over their biological behaviour, overcoming intrinsic limitations of the individual materials.
The Pharma Data
OCTOBER 9, 2021
Food and Drug Administration (FDA) for the treatment of people living with Alzheimer’s fever ( Notice). About Roche Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives.
XTalks
OCTOBER 12, 2022
However, the role of MRI in new drug clinical trials can involve diagnosis of lesions and determination of their severity, early identification of therapeutic responders to drug treatment and treatment monitoring and follow-up. Why Image Vascular Perfusion? An Example of an Anti-Angiogenic Therapy in Oncology.
Delveinsight
FEBRUARY 9, 2021
Deerfield Management has entered into a research agreement with Dana-Farber Cancer Institute to fuel the development of therapeutics and diagnostics for cancer. About time that the PI3K cancer drug portfolio has another member along with Gilead’s Zydelig, Verastem Oncology’s Copiktra, and Bayer’s Aliqopa.
Expert insights. Personalized for you.
52 
Let's personalize your content